Protein,Protein_definition,Disease_category,Disease,NB_individual,NB_case,OR[95%CI],P_value
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,Chapter I Certain infectious and parasitic diseases,Certain infectious and parasitic diseases,21789,777,0.99 [0.93-1.06],0.7209465217397292
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,Chapter I Certain infectious and parasitic diseases,Implicit bacterial Sepsis,21803,125,0.84 [0.72-0.99],0.0397738628122254
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,Chapter I Certain infectious and parasitic diseases,Intestinal infectious diseases,23170,134,1.09 [0.93-1.27],0.2774021259466629
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,Chapter I Certain infectious and parasitic diseases,Implicit Sepsis,17283,431,0.94 [0.86-1.02],0.1438033975213915
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,Chapter I Certain infectious and parasitic diseases,Other bacterial intestinal infections,23116,80,0.98 [0.80-1.20],0.849077832447136
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,Chapter I Certain infectious and parasitic diseases,Explicit Sepsis,22494,68,0.78 [0.63-0.97],0.0267605435405851
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,Chapter I Certain infectious and parasitic diseases,"Bacterial intestinal infections, IBD co-morbidities",23999,79,0.99 [0.81-1.22],0.956015755601208
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,Chapter I Certain infectious and parasitic diseases,Other specified/unspecified bacterial intestinal infections,24018,53,0.98 [0.76-1.25],0.8605604708492275
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,Chapter I Certain infectious and parasitic diseases,Implicit viral Sepsis,22020,40,1.21 [0.91-1.61],0.1808932385901239
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,Chapter I Certain infectious and parasitic diseases,Other bacterial diseases,23570,95,0.91 [0.76-1.10],0.3424800152712824
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,Chapter I Certain infectious and parasitic diseases,Other septicaemia,23533,58,0.73 [0.57-0.92],0.0089153834941308
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,Chapter I Certain infectious and parasitic diseases,Viral infections characterized by skin and mucous membrane lesions,24067,55,1.12 [0.88-1.43],0.3581332595852436
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,Chapter I Certain infectious and parasitic diseases,Other viral diseases,24021,91,1.13 [0.94-1.36],0.2060777892652306
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,Chapter I Certain infectious and parasitic diseases,"Other viral diseases, not elsewhere classified",24013,83,1.12 [0.92-1.36],0.2686936237629761
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,Chapter I Certain infectious and parasitic diseases,Mycoses,23853,44,1.09 [0.83-1.42],0.553031445155128
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,Chapter I Certain infectious and parasitic diseases,"Bacterial, viral and other infectious agents",23298,329,0.92 [0.83-1.01],0.0944322446197881
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,Chapter I Certain infectious and parasitic diseases,Streptococcus and staphylococcus as the cause of diseases classified to other chapters,23089,120,0.94 [0.80-1.11],0.450965182469674
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,Chapter I Certain infectious and parasitic diseases,Other bacterial agents as the cause of diseases classified to other chapters,23181,212,0.91 [0.80-1.03],0.1399506993535939
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,Chapter II Neoplasms,"Malignant neoplasm of colon, excluding all cancers (controls excluding all cancers)",20842,28,0.98 [0.70-1.38],0.9003617487938965
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",20859,45,0.92 [0.70-1.20],0.5417337323816669
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,Chapter II Neoplasms,"Other malignant neoplasms of skin (=non-melanoma skin cancer), excluding all cancers (controls excluding all cancers)",20925,111,1.09 [0.92-1.30],0.3105348485349868
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,Chapter II Neoplasms,"Squamous cell neoplasms and carcinomas of the skin, excluding all cancers (controls excluding all cancers)",20930,116,1.08 [0.92-1.28],0.3398096587176585
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,Chapter II Neoplasms,"Malignant neoplasm of breast, excluding all cancers (controls excluding all cancers)",11673,255,0.93 [0.83-1.04],0.1927392715252754
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",9417,21,1.28 [0.86-1.91],0.2174369342240116
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",20858,44,0.89 [0.68-1.16],0.3844001548416617
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,Chapter III Diseases of the blood and blood-forming organs and certain disorders involving the immune mechanism,Diseases of the blood and blood-forming organs and certain disorders involving the immune mechanism,22238,705,1.02 [0.95-1.09],0.6118040033770495
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,Chapter II Neoplasms,"Benign neoplasm of colon, rectum, anus and anal canal",23164,181,1.10 [0.96-1.25],0.1840983381233985
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,Chapter II Neoplasms,Benign neoplasm: Sigmoid colon,23708,73,0.93 [0.75-1.15],0.500766164060563
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,Chapter II Neoplasms,"Benign neoplasm: Colon, unspecified",24127,69,1.12 [0.90-1.39],0.3185765484995073
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,Chapter II Neoplasms,Benign neoplasm: Rectum,23921,40,1.46 [1.10-1.94],0.008615473642358
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,Chapter II Neoplasms,Benign neoplasm of other and ill-defined parts of digestive system,24129,33,0.92 [0.67-1.26],0.6035228264664901
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,Chapter II Neoplasms,Benign neoplasm: Stomach,24164,26,1.01 [0.71-1.44],0.9652934295593388
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,Chapter II Neoplasms,Benign lipomatous neoplasm,23898,250,0.91 [0.82-1.02],0.1227708710115974
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,Chapter II Neoplasms,Benign lipomatous neoplasm of skin and subcutaneous tissue of trunk,24108,103,0.85 [0.72-1.02],0.0828890123443431
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,Chapter II Neoplasms,Benign lipomatous neoplasm of skin and subcutaneous tissue of limbs,24110,76,0.93 [0.76-1.15],0.5029601263909806
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,Chapter II Neoplasms,"Haemangioma and lymphangioma, any site",24081,43,0.82 [0.63-1.08],0.1633602488113192
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,Chapter II Neoplasms,"Haemangioma, any site",24083,43,0.82 [0.63-1.08],0.1633721147184837
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,Chapter II Neoplasms,Melanocytic naevi,23981,209,1.04 [0.92-1.18],0.5251348840051875
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,Chapter II Neoplasms,Melanocytic naevi of other and unspecified parts of face,24127,95,1.14 [0.95-1.36],0.1715158431533664
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,Chapter II Neoplasms,Other benign neoplasms of skin,24042,164,1.02 [0.88-1.17],0.8050428072666538
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,Chapter II Neoplasms,Benign neoplasm of breast,13294,78,1.05 [0.86-1.29],0.6313102831416304
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,Chapter II Neoplasms,Leiomyoma of uterus,12991,597,1.00 [0.93-1.08],0.9782616607818438
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,Chapter III Diseases of the blood and blood-forming organs and certain disorders involving the immune mechanism,Other and unspecified iron deficiency,23300,167,1.02 [0.89-1.17],0.7954236915059409
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,Chapter III Diseases of the blood and blood-forming organs and certain disorders involving the immune mechanism,Other anaemias,23203,302,1.01 [0.91-1.12],0.8002220050188371
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,Chapter III Diseases of the blood and blood-forming organs and certain disorders involving the immune mechanism,Other and unspecified anaemias,23203,302,1.01 [0.91-1.12],0.8002220050188371
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,Chapter I Certain infectious and parasitic diseases,Condition for Implicit Sepsis (Organ dysfunction codes),22126,309,0.98 [0.88-1.08],0.6741080169484645
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,Chapter III Diseases of the blood and blood-forming organs and certain disorders involving the immune mechanism,Agranulocytosis,23724,70,0.88 [0.71-1.09],0.2487690589779745
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,"Chapter IV Endocrine, nutritional and metabolic diseases",Disorders of other endocrine glands,23944,88,1.02 [0.84-1.24],0.8486016044308141
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,"Chapter IV Endocrine, nutritional and metabolic diseases",Metabolic disorders,21186,614,1.03 [0.96-1.11],0.4157404186488704
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,"Chapter IV Endocrine, nutritional and metabolic diseases",Disorders of the thyroid gland,23057,373,1.02 [0.93-1.12],0.6745851642100755
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,"Chapter IV Endocrine, nutritional and metabolic diseases",Type 1 diabetes,22582,90,0.86 [0.71-1.04],0.1282970858320574
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,Chapter IX Diseases of the circulatory system,Peripheral artery disease,23491,51,0.94 [0.73-1.22],0.6502093724798896
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,"Chapter IV Endocrine, nutritional and metabolic diseases",Type 1 diabetes without complications,22570,78,0.87 [0.71-1.07],0.1975168678764416
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes,22770,278,0.94 [0.84-1.05],0.2944625080242595
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,22763,271,0.94 [0.84-1.05],0.2883673315230916
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,"Chapter IV Endocrine, nutritional and metabolic diseases",Obesity,22473,154,0.92 [0.79-1.09],0.3428457216575473
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,"Chapter IV Endocrine, nutritional and metabolic diseases","Obesity, other/unspecified",22477,152,0.94 [0.80-1.10],0.4343591475480122
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,"Chapter IV Endocrine, nutritional and metabolic diseases",Disorders of lipoprotein metabolism and other lipidaemias,21050,478,1.00 [0.92-1.08],0.9334580404245512
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,"Chapter IV Endocrine, nutritional and metabolic diseases","Hyperlipidaemia, other/unspecified",20638,66,0.84 [0.67-1.05],0.1287917327754492
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,"Chapter IV Endocrine, nutritional and metabolic diseases",Pure hypercholesterolaemia,21010,438,1.00 [0.92-1.10],0.9577457102198544
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,"Chapter IV Endocrine, nutritional and metabolic diseases",Volume depletion,20612,40,1.21 [0.91-1.60],0.1840747690492322
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,"Chapter IV Endocrine, nutritional and metabolic diseases","Other disorders of fluid, electrolyte and acid-base balance",20634,62,0.88 [0.70-1.11],0.2794966486858147
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,Chapter V Mental and behavioural disorders,Any mental disorder,20940,668,0.97 [0.90-1.04],0.375391812909542
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",20535,263,0.90 [0.80-1.01],0.072030547260822
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,Chapter V Mental and behavioural disorders,"Mental and behavioural disorders due to alcohol, excluding acute intoxication",23787,197,0.86 [0.75-0.98],0.0260900410566605
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,Chapter V Mental and behavioural disorders,"Alcohol use disorder, ICD-based",23841,143,0.88 [0.75-1.02],0.0951434736397408
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,Chapter V Mental and behavioural disorders,Acute alcohol intoxication,22427,69,0.79 [0.63-0.98],0.0338164750774098
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,Chapter V Mental and behavioural disorders,"Acute alcohol intoxication, ICD10",24065,69,0.79 [0.64-0.99],0.0375502977132224
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,Chapter V Mental and behavioural disorders,"Alcohol abuse, main dg, excluding more controls",20341,69,0.78 [0.63-0.98],0.0306363340280197
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,Chapter V Mental and behavioural disorders,Alcohol dependence,22443,85,0.75 [0.61-0.91],0.0047308225728467
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,Chapter V Mental and behavioural disorders,Smoking dependency,22409,64,1.01 [0.80-1.27],0.954270672865133
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,Chapter V Mental and behavioural disorders,"Schizophrenia or delusion, excluding more controls",20337,65,0.79 [0.63-0.99],0.0417736277858279
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,Chapter V Mental and behavioural disorders,"Mood disorders, excluding more controls",20603,331,0.98 [0.89-1.09],0.7487702898788683
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,Chapter V Mental and behavioural disorders,Depression,22642,287,0.99 [0.89-1.10],0.8117228353023478
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,Chapter V Mental and behavioural disorders,Depression or dysthymia,20479,251,1.01 [0.90-1.13],0.8708895269163826
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,Chapter V Mental and behavioural disorders,"Anxiety disorders, excluding more controls",20399,127,1.12 [0.95-1.31],0.173271740082096
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,Chapter V Mental and behavioural disorders,Other anxiety disorders,22865,56,1.00 [0.79-1.28],0.986232179582064
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,Chapter VI Diseases of the nervous system,Neurological diseases,21504,1275,1.00 [0.95-1.05],0.948376984788714
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,Chapter VI Diseases of the nervous system,Other degenerative diseases of the nervous system,20035,157,0.97 [0.84-1.12],0.6325455532244595
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,Chapter VI Diseases of the nervous system,MS-disease / Multiple Sclerosis,23977,127,1.00 [0.85-1.17],0.9537311579406444
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,Chapter VI Diseases of the nervous system,Episodal and paroxysmal disorders,23009,427,0.99 [0.91-1.09],0.8887231175965824
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,Chapter VI Diseases of the nervous system,Epilepsy,22727,145,0.89 [0.77-1.04],0.1444060530248732
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,Chapter VI Diseases of the nervous system,Migraine,22669,87,1.12 [0.92-1.36],0.2527399571146811
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,Chapter VI Diseases of the nervous system,"Migraine, unspecified, drug-induced",23840,77,1.15 [0.94-1.41],0.1813776963708008
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,Chapter IX Diseases of the circulatory system,Transient ischemic attack,23741,37,1.02 [0.76-1.38],0.8747843457606348
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,Chapter VI Diseases of the nervous system,Other sleep disorders,22733,151,0.99 [0.85-1.15],0.8554723896106
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,Chapter VI Diseases of the nervous system,Sleep apnoea,23629,118,1.01 [0.85-1.19],0.9421031583347644
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,Chapter VI Diseases of the nervous system,"Nerve, nerve root and plexus disorders",23171,536,1.01 [0.93-1.09],0.8947813643465652
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,Chapter VI Diseases of the nervous system,"Other and unspecified nerve root and plexus disorders, also in other diseases",22760,125,1.05 [0.89-1.23],0.5738114127148889
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,Chapter VI Diseases of the nervous system,Carpal tunnel syndrome,22920,285,1.02 [0.92-1.14],0.6654236820392645
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,Chapter VI Diseases of the nervous system,Cerebral palsy and other paralytic syndromes,23976,78,1.10 [0.90-1.35],0.3503568142219145
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,Chapter VI Diseases of the nervous system,Hemiplegia,23950,52,1.03 [0.80-1.32],0.805543997920015
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,Chapter VI Diseases of the nervous system,Other neurological diseases,23782,106,0.86 [0.72-1.03],0.0987043305569224
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Disorders of eyelid, lacrimal system and orbit",23758,273,1.01 [0.90-1.12],0.886580650224868
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Other disorders of eyelid,23632,147,1.05 [0.91-1.22],0.516369559817875
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Chalazion,23564,79,0.97 [0.79-1.18],0.7365099414112994
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Other specified and unspecified  disorders of eyelid,23573,88,1.02 [0.84-1.24],0.8176376039008555
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Disorders of lacrimal system,23526,41,1.08 [0.82-1.43],0.592557956824422
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Senile cataract,22656,54,1.14 [0.89-1.45],0.312602953713491
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Other cataract,22767,165,1.00 [0.86-1.15],0.9456161492347236
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Disorders of choroid and retina,23627,109,1.00 [0.84-1.19],0.970706301035788
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Background diabetic retinopathy,23951,18,1.06 [0.70-1.62],0.7846837492815188
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Diabetic maculopathy,1531,18,1.06 [0.70-1.60],0.7769174258703389
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic maculopathy, excluding more controls",22438,18,1.06 [0.70-1.62],0.7752093856530878
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Glaucoma,23832,43,1.11 [0.84-1.46],0.4551827724648556
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Other and unspecified glaucoma,23812,23,0.85 [0.58-1.24],0.3915760814298636
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Disorders of ocular muscles, binocular movement, accommodation and refraction",23749,83,0.93 [0.76-1.14],0.4844127429470138
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual disturbances,23803,87,0.97 [0.80-1.18],0.7626383470674738
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Diseases of middle ear and mastoid,24049,111,1.00 [0.84-1.18],0.9706986171935262
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Other disorders of ear,23698,85,1.10 [0.90-1.33],0.3583729375284517
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,Chapter IX Diseases of the circulatory system,Death due to cardiac causes,18860,1717,1.00 [0.95-1.05],0.944671110833296
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,Chapter IX Diseases of the circulatory system,Rheumatic valve diseases,23887,37,0.74 [0.55-1.00],0.0516542134812409
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,Chapter IX Diseases of the circulatory system,"Hypertension, essential",19776,1144,1.02 [0.96-1.08],0.5946845319933445
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,Chapter IX Diseases of the circulatory system,Hypertension,19793,1161,1.01 [0.95-1.07],0.7224636142254179
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,Chapter IX Diseases of the circulatory system,Hypertensive Renal Disease,18663,31,0.79 [0.57-1.10],0.1591396793813603
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,Chapter IX Diseases of the circulatory system,"Ischaemic heart disease, wide definition",22859,499,0.90 [0.83-0.98],0.0171764545200733
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,Chapter IX Diseases of the circulatory system,Angina pectoris,22661,301,0.91 [0.81-1.01],0.070895888507656
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,Chapter IX Diseases of the circulatory system,Unstable angina pectoris,23543,119,0.88 [0.75-1.05],0.1485963734246864
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,Chapter IX Diseases of the circulatory system,Major coronary heart disease event,23649,225,0.88 [0.78-0.99],0.037642267753128
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,Chapter IX Diseases of the circulatory system,"Myocardial infarction, with ST-elevation",24073,50,0.80 [0.62-1.04],0.0981789317324571
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,Chapter IX Diseases of the circulatory system,"Myocardial infarction, strict",22499,139,0.92 [0.79-1.08],0.3063605538299283
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,Chapter IX Diseases of the circulatory system,Coronary atherosclerosis,22727,377,0.90 [0.82-1.00],0.0398885504832707
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,Chapter IX Diseases of the circulatory system,Pulmonary embolism,23710,75,1.09 [0.89-1.35],0.3963300071463057
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,Chapter IX Diseases of the circulatory system,Venous thromboembolism,23721,153,1.02 [0.88-1.18],0.8048878007860727
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,Chapter IX Diseases of the circulatory system,Secondary right heart disease,23695,60,1.03 [0.82-1.30],0.7789980482501608
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,Chapter IX Diseases of the circulatory system,Other pulmonary heart/vessel disease,23696,61,1.04 [0.83-1.31],0.7249144595083908
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,Chapter IX Diseases of the circulatory system,"Hypertension, Pulmonary Arterial",18689,57,1.03 [0.81-1.31],0.8135091487760375
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,Chapter IX Diseases of the circulatory system,Cardiomyopathy,21869,41,1.06 [0.80-1.41],0.6788410600367132
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,Chapter IX Diseases of the circulatory system,Conduction disorders,21894,66,1.14 [0.91-1.42],0.2509391032827369
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,Chapter IX Diseases of the circulatory system,Paroxysmal tachycardia,16440,84,1.11 [0.91-1.35],0.2985225409570254
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,Chapter IX Diseases of the circulatory system,Atrial fibrillation and flutter,16529,173,1.07 [0.93-1.23],0.351158942665192
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,Chapter IX Diseases of the circulatory system,Other arrhythmias,21863,35,1.17 [0.86-1.57],0.3139679883484051
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,Chapter IX Diseases of the circulatory system,Other or ill-defined heart diseases,21880,52,0.78 [0.61-1.00],0.0510114308456985
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,Chapter IX Diseases of the circulatory system,"Heart failure, strict",23717,109,1.12 [0.94-1.33],0.2179122944370692
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,Chapter IX Diseases of the circulatory system,"Stroke, including SAH",23692,98,1.01 [0.85-1.22],0.8763839589017253
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,Chapter IX Diseases of the circulatory system,"Stroke, excluding SAH",23723,73,1.10 [0.89-1.35],0.3926441636984222
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,Chapter IX Diseases of the circulatory system,"Ischaemic Stroke, excluding all haemorrhages",23766,62,1.12 [0.89-1.41],0.3199900459494696
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,Chapter IX Diseases of the circulatory system,Other diseases of arteries and capillaries,23508,46,0.87 [0.66-1.14],0.304906450795685
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,Chapter IX Diseases of the circulatory system,Other peripheral vascular diseases,23535,73,1.03 [0.83-1.27],0.7934935064693064
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,Chapter IX Diseases of the circulatory system,Phlebitis and thrombophlebitis (not including DVT),23107,99,1.09 [0.91-1.30],0.3755993829207394
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,Chapter IX Diseases of the circulatory system,DVT of lower extremities,23091,83,1.12 [0.92-1.36],0.2717235825904972
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,Chapter IX Diseases of the circulatory system,"!Phlebitis/thrombophlebitis venae iliacae [externae/internae/communis], drug-induced",24028,81,1.14 [0.93-1.39],0.2024234270057616
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,Chapter IX Diseases of the circulatory system,Varicose veins,23389,381,0.86 [0.79-0.95],0.0023101760501648
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,Chapter IX Diseases of the circulatory system,Hypotension,23523,44,1.15 [0.88-1.51],0.3087101871516673
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,Chapter X Diseases of the respiratory system,Diseases of the respiratory system,20430,1702,1.01 [0.97-1.06],0.6275779828610366
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,Chapter X Diseases of the respiratory system,Acute upper respiratory infections,23963,113,1.01 [0.86-1.20],0.8730624776588451
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,Chapter X Diseases of the respiratory system,Influenza and pneumonia,23121,160,1.07 [0.93-1.23],0.3646977417302868
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,Chapter X Diseases of the respiratory system,"Pneumonia, organism unspecified",23097,136,1.09 [0.94-1.28],0.2529425690315205
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,Chapter X Diseases of the respiratory system,Other acute lower respiratory infections,23615,192,0.96 [0.84-1.10],0.5504410534736017
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,Chapter X Diseases of the respiratory system,Unspecified acute lower respiratory infection,23614,191,0.96 [0.84-1.10],0.5485474060322817
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,Chapter X Diseases of the respiratory system,Other diseases of upper respiratory tract,23383,578,1.04 [0.97-1.13],0.2610650101107488
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,Chapter X Diseases of the respiratory system,Chronic sinusitis,22895,90,1.21 [1.00-1.46],0.0469582205124121
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,Chapter X Diseases of the respiratory system,Nasal polyp,22901,96,1.09 [0.91-1.31],0.351817328600886
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,Chapter X Diseases of the respiratory system,"Diseases of vocal cords and larynx+other diseases of upper respiratory tract, no elsewhere classified",23175,370,1.05 [0.96-1.16],0.2844338913012926
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,Chapter X Diseases of the respiratory system,Deviated nasal septum,23001,196,1.13 [1.00-1.29],0.0548358324530868
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,Chapter X Diseases of the respiratory system,Vocal cord dysfunction,13877,41,1.13 [0.85-1.51],0.3864616208750608
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,Chapter X Diseases of the respiratory system,Chronic lower respiratory diseases,22102,767,0.97 [0.91-1.04],0.4240185651007448
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,Chapter X Diseases of the respiratory system,Early onset COPD,23547,90,0.93 [0.77-1.14],0.4932749000833412
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,Chapter X Diseases of the respiratory system,"COPD, hospital admissions 1, only main diagnosis",23547,90,0.93 [0.77-1.14],0.4932749000833412
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,Chapter X Diseases of the respiratory system,"Other chronic obstructive pulmonary disease, including avohilmo",23547,90,0.93 [0.77-1.14],0.4932749000833412
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,Chapter X Diseases of the respiratory system,"Asthma, hospital admissions , main diagnosis only",22614,695,0.98 [0.91-1.05],0.4817965647613521
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,Chapter X Diseases of the respiratory system,Asthma,18443,695,0.97 [0.91-1.04],0.4422209196372024
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,Chapter X Diseases of the respiratory system,"Asthma, excluding more controls",18311,695,0.97 [0.91-1.04],0.4366319699503533
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,Chapter X Diseases of the respiratory system,"Asthma, unspecified (mode)",18428,680,0.97 [0.90-1.04],0.4098904990647797
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,Chapter X Diseases of the respiratory system,Other respiratory diseases principally affecting the interstitium,23996,55,0.93 [0.73-1.18],0.538674700727115
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,Chapter X Diseases of the respiratory system,Interstitial lung disease,22980,42,0.77 [0.58-1.02],0.0663841408576041
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,Chapter X Diseases of the respiratory system,"ILD, hospital admissions",24050,42,0.77 [0.58-1.02],0.0714536268842973
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,Chapter X Diseases of the respiratory system,Idiopathic pulmonary fibrosis,22974,36,0.74 [0.55-1.01],0.0556720616549719
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,Chapter X Diseases of the respiratory system,Pleural effusion,22981,67,1.06 [0.85-1.32],0.607570507731423
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,Chapter X Diseases of the respiratory system,Other diseases of pleura,23076,162,1.02 [0.88-1.17],0.8134518780189619
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,Chapter X Diseases of the respiratory system,Other respiratory disorders and diseases,23427,76,1.01 [0.82-1.25],0.8999829090514935
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,Chapter XI Diseases of the digestive system,Gastrointestinal diseases,17158,4496,1.01 [0.98-1.04],0.6115572462004255
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,Chapter XI Diseases of the digestive system,"Diseases of oral cavity, salivary glands and jaws",23634,430,1.04 [0.95-1.14],0.3693258837755139
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,Chapter XI Diseases of the digestive system,Embedded and impacted teeth,24102,118,0.98 [0.83-1.16],0.8575236706626965
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,Chapter XI Diseases of the digestive system,Impacted teeth,24107,109,1.00 [0.84-1.18],0.9661940979223984
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,Chapter XI Diseases of the digestive system,Dental caries,23311,107,1.12 [0.94-1.33],0.2077852032477598
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,Chapter XI Diseases of the digestive system,Diseases of pulp and periapical tissues,23303,99,1.10 [0.92-1.32],0.3137803438741374
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,Chapter XI Diseases of the digestive system,Palatinal maxillary canine,24089,134,1.00 [0.86-1.17],0.9922560375705238
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,Chapter XI Diseases of the digestive system,Other disorders of teeth and supporting structures,23283,79,1.16 [0.95-1.42],0.137826752898348
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,Chapter XI Diseases of the digestive system,Other diseases of lip and oral mucosa,23069,55,0.89 [0.70-1.14],0.3561745807591129
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,Chapter XI Diseases of the digestive system,Oral lichen ruber planus,24055,40,0.81 [0.61-1.08],0.1458283657476492
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,Chapter XI Diseases of the digestive system,Gastroduodenal ulcer,19428,184,0.89 [0.78-1.02],0.0852254413813292
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,Chapter XI Diseases of the digestive system,"Diseases of oesophagus, stomach and duodenum",20784,1540,0.99 [0.95-1.04],0.724830578176862
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,Chapter XI Diseases of the digestive system,Oesophagitis,19477,233,1.08 [0.96-1.22],0.2048020556783352
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,Chapter XI Diseases of the digestive system,Gastro-oesophageal reflux disease,19740,496,0.98 [0.90-1.06],0.593455131133695
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,Chapter XI Diseases of the digestive system,Other diseases of oesophagus,19305,61,1.08 [0.86-1.36],0.5098073011801725
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,Chapter XI Diseases of the digestive system,Ulcer of oesophagus,19366,122,0.97 [0.83-1.15],0.7612872818820731
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,Chapter XI Diseases of the digestive system,Oesophageal obstruction,19269,25,0.93 [0.64-1.33],0.6764692612667851
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,Chapter XI Diseases of the digestive system,Gastric ulcer,19336,92,0.86 [0.71-1.04],0.1186788185765203
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,Chapter XI Diseases of the digestive system,Duodenal ulcer,19338,94,0.84 [0.70-1.02],0.072206108009667
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,Chapter XI Diseases of the digestive system,"Duodenal ulcer - Unspecified as acute or chronic, without haemorrhage or perforation, drug-induced",24071,65,0.85 [0.68-1.06],0.1547908084852661
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,Chapter XI Diseases of the digestive system,Chronic gastritis,19340,96,0.89 [0.74-1.08],0.2305752165752751
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,Chapter XI Diseases of the digestive system,Other gastritis (incl. Duodenitis),19810,566,1.00 [0.92-1.08],0.9605691522466356
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,Chapter XI Diseases of the digestive system,Diseases of appendix,24001,142,1.01 [0.87-1.17],0.9393144697926707
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,Chapter XI Diseases of the digestive system,Functional dyspepsia,19583,339,1.07 [0.97-1.18],0.1823115806025123
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,Chapter XI Diseases of the digestive system,Other diseases of stomach and duodenum,19345,101,0.83 [0.69-1.00],0.04704789598882
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,Chapter XI Diseases of the digestive system,Colonic or urogenital fistula,23990,169,0.95 [0.83-1.09],0.4581815322468162
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,Chapter XI Diseases of the digestive system,Acute appendicitis,23971,112,0.96 [0.81-1.14],0.6275666250893204
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,Chapter XI Diseases of the digestive system,Hernia,21790,1037,1.01 [0.96-1.07],0.6403491561025647
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,Chapter XI Diseases of the digestive system,Inguinal hernia,21097,344,1.04 [0.94-1.14],0.4889890061862486
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,Chapter XI Diseases of the digestive system,Umbilical hernia,20855,102,1.00 [0.84-1.20],0.963575481809766
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,Chapter XI Diseases of the digestive system,Ventral hernia,20831,78,0.94 [0.76-1.15],0.5264318208250307
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,Chapter XI Diseases of the digestive system,Diaphragmatic hernia,21292,539,1.01 [0.94-1.10],0.7410586842695098
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,Chapter XI Diseases of the digestive system,Noninfective enteritis and colitis,23407,654,1.06 [0.99-1.14],0.0911543919420998
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,Chapter XI Diseases of the digestive system,Other diseases of intestines,19887,1454,0.99 [0.94-1.04],0.703528856420911
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,Chapter XI Diseases of the digestive system,"Crohn disease (strict definition, all UC cases excluded)",23875,66,0.93 [0.75-1.16],0.5279006423827275
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,Chapter XI Diseases of the digestive system,"Crohn disease (strict definition, require KELA, min 2 HDR)",24091,93,1.06 [0.88-1.27],0.5570897283648739
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,Chapter XI Diseases of the digestive system,Crohn disease,22846,93,1.06 [0.88-1.28],0.5288443791036106
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,Chapter XI Diseases of the digestive system,Crohn's disease NAS,22826,73,1.08 [0.88-1.34],0.4480483143930712
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,Chapter XI Diseases of the digestive system,"Ulcerative colitis (strict definition, require KELA, min 2 HDR)",24041,111,1.11 [0.94-1.32],0.2165388752478306
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,Chapter XI Diseases of the digestive system,Ulcerative colitis,22864,111,1.12 [0.94-1.32],0.2050552624471343
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,Chapter XI Diseases of the digestive system,"Ulcerative colitis, NAS",22847,94,1.11 [0.92-1.33],0.2830524189197246
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,Chapter XI Diseases of the digestive system,Other noninfective gastroenteritis and colitis,23280,527,1.07 [0.99-1.16],0.0977908576095537
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,Chapter XI Diseases of the digestive system,Noninfectious colitis NAS,23276,523,1.07 [0.99-1.16],0.0861318942118608
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,Chapter XI Diseases of the digestive system,Paralytic ileus and intestinal obstruction,18497,64,1.06 [0.85-1.33],0.5940923904130002
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,Chapter XI Diseases of the digestive system,Intestinal stricture,23860,64,1.06 [0.85-1.33],0.605377755033471
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,Chapter XI Diseases of the digestive system,"Other or unspecified ileus, impaction or obstruction",18479,46,1.09 [0.84-1.42],0.5323553969174153
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,Chapter XI Diseases of the digestive system,Diverticular disease of intestine,18702,269,1.00 [0.90-1.12],0.9495444570477924
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,Chapter XI Diseases of the digestive system,Irritable bowel syndrome,18582,149,0.99 [0.85-1.14],0.8632502214701134
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,Chapter XI Diseases of the digestive system,Other functional intestinal disorders,18652,219,1.10 [0.98-1.24],0.114812038087984
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,Chapter XI Diseases of the digestive system,Constipation,23149,194,1.11 [0.98-1.27],0.1054249205501612
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,Chapter XI Diseases of the digestive system,Diseases of peritoneum,23783,77,1.02 [0.83-1.25],0.8491810942311251
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,Chapter XI Diseases of the digestive system,Fissure and fistula of anal and rectal regions,18591,158,0.97 [0.84-1.12],0.6507819395244256
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,Chapter XI Diseases of the digestive system,Abscess of anal and rectal regions,18518,85,0.92 [0.76-1.12],0.4327740835600597
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,Chapter XI Diseases of the digestive system,Other diseases of anus and rectum,19121,688,0.99 [0.92-1.06],0.6817100984467268
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,Chapter XI Diseases of the digestive system,Other diseases of intestine,18587,154,0.79 [0.69-0.92],0.0021145754773017
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,Chapter XI Diseases of the digestive system,Other diseases of peritoneum,23771,65,1.01 [0.81-1.26],0.9467810066493734
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,Chapter XI Diseases of the digestive system,Diseases of liver,23524,110,0.71 [0.60-0.85],0.0001521936700236
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,Chapter XI Diseases of the digestive system,Other diseases of liver,23477,63,0.73 [0.58-0.93],0.0087199345199888
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,Chapter XI Diseases of the digestive system,"Disorders of gallbladder, biliary tract and pancreas",23057,447,0.97 [0.89-1.06],0.4677332516962555
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,Chapter XI Diseases of the digestive system,Cholelithiasis,22967,357,0.97 [0.88-1.06],0.4760625679555236
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,Chapter XI Diseases of the digestive system,Cholecystitis,22673,63,1.15 [0.92-1.45],0.2110895744633584
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,Chapter XI Diseases of the digestive system,Other diseases of biliary tract,22647,37,0.99 [0.74-1.33],0.9583185780884164
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,Chapter XI Diseases of the digestive system,Acute pancreatitis,22659,49,0.70 [0.54-0.91],0.0081926680332146
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,Chapter XI Diseases of the digestive system,Acute pancreatitis (for exclusion),24002,49,0.70 [0.54-0.91],0.0082573062690067
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,Chapter XI Diseases of the digestive system,Diseases of the digestive system,23077,248,1.02 [0.90-1.14],0.7945910745948828
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,Chapter XI Diseases of the digestive system,Intestinal malabsorption,22887,58,1.02 [0.81-1.30],0.8449222943504645
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,Chapter XI Diseases of the digestive system,Coeliac disease,22877,48,1.04 [0.80-1.35],0.765365076366539
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,Chapter XI Diseases of the digestive system,"Postprocedural disorders of digestive system, not elsewhere classified",22866,37,1.12 [0.83-1.50],0.4614808600968002
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,Chapter XI Diseases of the digestive system,Other diseases of the digestive system,22986,157,1.03 [0.89-1.19],0.6915852897681933
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,Chapter XI Diseases of the digestive system,GI-bleeding,22981,152,1.02 [0.88-1.18],0.81488296606643
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,Chapter XII Diseases of the skin and subcutaneous tissue,Diseases of the skin and subcutaneous tissue,21924,1280,0.95 [0.90-1.00],0.0455450182975156
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,Chapter XII Diseases of the skin and subcutaneous tissue,Dermatitis and eczema,23834,87,0.87 [0.72-1.06],0.1707132071530736
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,Chapter XII Diseases of the skin and subcutaneous tissue,Disorders of skin appendages,23797,409,0.95 [0.87-1.04],0.2320468535273255
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,Chapter XII Diseases of the skin and subcutaneous tissue,Other disorders of skin and subcutaneous tissue,23200,447,0.95 [0.87-1.03],0.2145349395049757
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,Chapter XII Diseases of the skin and subcutaneous tissue,Infections of the skin and subcutaneous tissue,23472,350,0.96 [0.87-1.06],0.4026710450904339
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,Chapter XII Diseases of the skin and subcutaneous tissue,"Cutaneous abscess, furuncle and carbuncle",23216,94,0.90 [0.75-1.09],0.2883532485438852
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,Chapter XII Diseases of the skin and subcutaneous tissue,Cellulitis,23320,198,0.95 [0.84-1.09],0.4830888792743568
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,Chapter XII Diseases of the skin and subcutaneous tissue,Papulosquamous disorders,23935,73,0.86 [0.70-1.06],0.1658743331464202
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,Chapter XII Diseases of the skin and subcutaneous tissue,Psoriasis,23923,61,0.91 [0.72-1.15],0.425374685836683
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,Chapter XII Diseases of the skin and subcutaneous tissue,Other and unspecified psoriasis,23906,44,0.92 [0.70-1.20],0.5368879213430257
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,Chapter XII Diseases of the skin and subcutaneous tissue,Radiation-related disorders of the skin and subcutaneous tissue,24023,28,1.07 [0.76-1.50],0.6879102276485392
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,Chapter XII Diseases of the skin and subcutaneous tissue,Skin changes due to chronic exposure to nonionizing radiation,24020,25,1.06 [0.74-1.51],0.7552684206988141
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,Chapter XII Diseases of the skin and subcutaneous tissue,Nail disorders,23445,57,1.09 [0.86-1.39],0.4655724343105816
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,Chapter XII Diseases of the skin and subcutaneous tissue,Follicular cysts of skin and subcutaneous tissue,23700,312,0.96 [0.86-1.06],0.4118855927990945
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,Chapter XII Diseases of the skin and subcutaneous tissue,Seborrhoeic keratosis,22809,56,0.97 [0.76-1.24],0.8071763069921206
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,Chapter XII Diseases of the skin and subcutaneous tissue,Atrophic disorders of skin,22834,81,0.85 [0.69-1.04],0.1066510341682187
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,Chapter XII Diseases of the skin and subcutaneous tissue,Scar conditions and fibrosis of skin,22821,68,0.83 [0.67-1.03],0.0966029874644699
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,Chapter XII Diseases of the skin and subcutaneous tissue,"Other disorders of skin and subcutaneous tissue, not elsewhere classified",22928,175,0.99 [0.86-1.13],0.8736162534071527
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,Chapter XII Diseases of the skin and subcutaneous tissue,Other and unspecified disorders of skin and subcutaneous tissue,22906,153,0.94 [0.81-1.09],0.4223468448488529
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Diseases of the musculoskeletal system and connective tissue,18680,3058,0.98 [0.95-1.02],0.357031299113685
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Arthropathies,20078,1625,1.00 [0.95-1.04],0.8625253689330932
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Soft tissue disorders,22017,958,1.07 [1.01-1.14],0.0241170317854454
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Rheumatoid arthritis,18565,112,0.97 [0.82-1.15],0.7307405127256219
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Polyarthropathies,18760,307,0.93 [0.84-1.04],0.1881898777999427
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,"Other (seronegative) rheumatoid arthritis, wide",23864,107,0.99 [0.83-1.17],0.865812269999777
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Other/unspecified rheumatoid arthritis,23877,95,0.95 [0.79-1.14],0.5615207016566708
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Arthrosis,19029,576,1.02 [0.94-1.10],0.7068096707675535
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,"Artrosis, including avohilmo",21280,576,1.02 [0.94-1.10],0.6544191071197092
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Gout,18492,39,1.09 [0.81-1.46],0.5623046980700644
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,"Gout, unspecified",23830,38,1.10 [0.82-1.47],0.5233770992369134
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Other specified/unspecified arthritis,18584,131,0.83 [0.71-0.98],0.0274632299592398
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Polyarthrosis,18474,21,1.11 [0.74-1.64],0.6200290098423016
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Coxarthrosis,18562,109,0.94 [0.78-1.11],0.4541295181128291
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,"Coxarthrosis, primary",24061,57,0.98 [0.77-1.24],0.8588148772630182
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Gonarthrosis,18743,290,1.06 [0.95-1.18],0.3221943246295103
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Other arthrosis,18645,192,1.01 [0.89-1.16],0.8532663632084556
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Other joint disorders,19523,1070,1.00 [0.94-1.06],0.9448829428005672
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Other deformities of toe(s),18491,38,1.16 [0.87-1.55],0.3210248264028527
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Hallux valgus (acquired),18605,152,0.98 [0.85-1.14],0.8095751066965731
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Hallux rigidus,18477,24,0.94 [0.65-1.36],0.7458384814988464
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Other hammer toe(s) (acquired),18479,26,1.09 [0.76-1.55],0.6413999959435961
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Internal derangement of knee,18892,439,1.07 [0.98-1.17],0.1174101837857179
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Meniscus derangement,18820,367,1.09 [0.99-1.20],0.0841768536361414
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Pain in joint,19078,244,0.95 [0.84-1.06],0.3504854024968152
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Systemic lupus erythematosus,23809,144,0.89 [0.77-1.04],0.1333142935845825
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Other systemic involvement of connective tissue,23702,37,0.76 [0.56-1.02],0.0688566701492063
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Deforming dorsopathies,21563,44,0.91 [0.69-1.19],0.4876778287183672
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Spondylopathies,21714,195,0.85 [0.74-0.96],0.0125676734367254
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Dorsopathies,22319,800,0.94 [0.88-1.00],0.0473890274089563
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Spondylosis,21642,123,0.93 [0.79-1.10],0.3977047889501164
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Spinal stenosis,21568,49,0.74 [0.57-0.96],0.0214823436640677
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,"Other dorsopathies, not elsewhere classified",22196,677,0.95 [0.89-1.02],0.1625898637327099
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Cervical disc disorders,21569,50,0.96 [0.74-1.24],0.7359889845620916
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Other intervertebral disc disorders,21750,231,0.96 [0.85-1.08],0.5093796360992016
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Lumbar disc prolapse,21621,102,0.98 [0.82-1.17],0.7990430340029178
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Sciatica+with lumbago,21580,61,1.02 [0.81-1.29],0.8384202713196762
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Other/unspecified dorsalgia,21645,126,0.90 [0.76-1.06],0.195577897442543
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Cervicalgia,21579,60,1.05 [0.83-1.33],0.6800020400206935
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Low back pain,21807,288,1.04 [0.94-1.16],0.4609457944049414
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Disorders of synovium and tendon,21304,245,1.03 [0.91-1.15],0.6626341931976214
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Other/unspecified synovitis and tenosynovitis,21107,48,0.94 [0.72-1.23],0.657532932993908
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Trigger finger,21101,42,0.94 [0.71-1.24],0.6775187608800379
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Ganglion,21162,103,1.12 [0.94-1.33],0.2123343594497031
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,"Soft tissue disorders related to use, overuse and pressure",21111,52,1.04 [0.81-1.34],0.7454783295073075
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Fibroblastic disorders,21113,54,1.01 [0.79-1.29],0.9538717895165962
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Palmar fascial fibromatosis [Dupuytren],21101,42,0.94 [0.71-1.24],0.6639387497209636
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Shoulder lesions,21245,186,0.96 [0.84-1.10],0.5565450127524507
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Other shoulder lesions,21105,46,0.95 [0.73-1.24],0.7054866389102801
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Rotator cuff syndrome,21103,44,0.99 [0.75-1.30],0.9338043373485444
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Impingement syndrome of shoulder,21152,93,1.01 [0.84-1.22],0.8873183603606589
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Other enthesopathies,21124,65,1.05 [0.84-1.31],0.6699904838547721
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,"Other soft tissue disorders, not elsewhere classified",21445,386,1.14 [1.04-1.25],0.0063894672286172
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Other specified/unspecified soft tissue disorders,21191,132,1.04 [0.89-1.22],0.611000048346521
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Pain in limb,21260,201,1.23 [1.08-1.39],0.0015185276847025
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Osteoporosis,22928,91,1.01 [0.84-1.22],0.8901086192310198
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Osteopathies and chondropathies,23131,294,0.93 [0.84-1.04],0.1990302575058953
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Disorders of continuity of bone,22886,49,0.90 [0.69-1.16],0.4100894086663147
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Other specified/unspecified disorders of  bone/cartilage,22893,56,0.95 [0.74-1.20],0.6549745322080065
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Other disorders of bone,22938,101,0.87 [0.73-1.04],0.1239189108480735
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,Chapter XIV Diseases of the genitourinary system,Genitourinary diseases,20444,3796,0.98 [0.95-1.01],0.1642771875762652
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,Chapter XIV Diseases of the genitourinary system,Diseases of male genital organs,9826,351,1.00 [0.91-1.11],0.9420460978487828
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,Chapter XIV Diseases of the genitourinary system,Renal tubulo-interstitial diseases,22872,156,0.85 [0.74-0.99],0.0321932811785889
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,Chapter XIV Diseases of the genitourinary system,Other obstructive and reflux uropathy,22760,44,0.93 [0.71-1.23],0.6179376942159389
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,Chapter XIV Diseases of the genitourinary system,Acute renal failure,23018,32,0.63 [0.46-0.87],0.0052860530444573
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,Chapter XIV Diseases of the genitourinary system,Chronic kidney disease,23017,31,0.79 [0.57-1.09],0.1504154937070009
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,Chapter XIV Diseases of the genitourinary system,Unspecified kidney failure,23024,38,0.91 [0.68-1.22],0.5326225447141899
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,Chapter XIV Diseases of the genitourinary system,Urolithiasis,23838,205,1.03 [0.91-1.17],0.6219033706428496
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,Chapter XIV Diseases of the genitourinary system,Other disorders of kidney and ureter,23910,48,1.07 [0.82-1.39],0.613542109968773
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,Chapter XIV Diseases of the genitourinary system,Calculus of kidney and ureter,23775,142,0.96 [0.82-1.11],0.5795387507226737
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,Chapter XIV Diseases of the genitourinary system,Unspecified renal colic,23717,84,1.17 [0.96-1.42],0.1095375423262834
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,Chapter XIV Diseases of the genitourinary system,Other diseases of urinary system,22829,761,0.98 [0.92-1.05],0.5743382149812997
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,Chapter XIV Diseases of the genitourinary system,Cystitis,22136,68,0.88 [0.71-1.10],0.2722587274081902
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,Chapter XIV Diseases of the genitourinary system,Neuromuscular dysfunction of bladder,22125,57,1.11 [0.87-1.40],0.4104618248105359
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,Chapter XIV Diseases of the genitourinary system,Other disorders of  bladder,22221,153,1.01 [0.87-1.17],0.8823510774530584
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,Chapter XIV Diseases of the genitourinary system,Urethral stricture,22148,80,0.94 [0.77-1.15],0.5359993960605474
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,Chapter XIV Diseases of the genitourinary system,Other disorders of urethra and urinary system,22604,536,0.99 [0.92-1.07],0.8315755179277775
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,Chapter XIV Diseases of the genitourinary system,Hyperplasia of prostate,9536,61,1.23 [0.97-1.55],0.0897877737028233
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,Chapter XIV Diseases of the genitourinary system,Inflammatory diseases of prostate (prostatitis),9508,33,0.91 [0.66-1.25],0.5476619796089695
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,Chapter XIV Diseases of the genitourinary system,Hydrocele,9509,34,0.93 [0.68-1.26],0.6345898143752612
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,Chapter XIV Diseases of the genitourinary system,"Redundant prepuce, phimosis and paraphimosis",9547,72,1.01 [0.82-1.25],0.9034666697103744
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,Chapter XIV Diseases of the genitourinary system,Other disorders of penis,9533,58,1.07 [0.84-1.36],0.5889204027769976
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,Chapter XIV Diseases of the genitourinary system,Other disorders of male genital organs,9560,85,0.88 [0.72-1.07],0.2078233475820663
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,Chapter XIV Diseases of the genitourinary system,Disorders of breast,13171,215,0.95 [0.84-1.07],0.4088573934385322
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,Chapter XIV Diseases of the genitourinary system,Benign mammary dysplasia,13022,66,0.95 [0.76-1.18],0.6414932830406375
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,Chapter XIV Diseases of the genitourinary system,Unspecified lump in breast,13026,70,1.03 [0.84-1.28],0.7601819647908786
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,Chapter XIV Diseases of the genitourinary system,Other disorders of breast,13004,48,0.87 [0.67-1.12],0.2708878798232987
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,Chapter XIV Diseases of the genitourinary system,Inflammatory diseases of female pelvic organs,13137,335,1.02 [0.92-1.12],0.7180429659848906
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,Chapter XIV Diseases of the genitourinary system,Inflammatory disease of cervix uteri,12873,71,1.02 [0.82-1.26],0.8613550031254631
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,Chapter XIV Diseases of the genitourinary system,Other female pelvic inflammatory diseases,12970,168,1.03 [0.90-1.19],0.6544959552887506
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,Chapter XIV Diseases of the genitourinary system,Noninflammatory disorders of female genital tract,12108,2396,1.00 [0.96-1.04],0.9447971012100496
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,Chapter XIV Diseases of the genitourinary system,Endometriosis,9966,254,1.11 [0.99-1.24],0.0772585650800366
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,Chapter XIV Diseases of the genitourinary system,Unspecified/other endometriosis,9792,80,1.33 [1.09-1.62],0.005480713777228
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,Chapter XIV Diseases of the genitourinary system,Adenomyosis (Endometriosis of uterus),9814,102,1.08 [0.90-1.29],0.4206947671316341
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,Chapter XIV Diseases of the genitourinary system,Female genital prolapse,9981,269,1.08 [0.97-1.21],0.162837542172389
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,Chapter XIV Diseases of the genitourinary system,Ovarian cyst,9979,267,0.95 [0.85-1.06],0.3527565428643208
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,Chapter XIV Diseases of the genitourinary system,Polyp of the female genital tract,10127,415,0.95 [0.87-1.04],0.2970759360532282
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,Chapter XIV Diseases of the genitourinary system,Uterine polyps,9856,144,0.90 [0.77-1.05],0.1666594333391362
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,Chapter XIV Diseases of the genitourinary system,"Other noninflammatory disorders of uterus, except cervix",9899,187,1.03 [0.91-1.18],0.6134929378304024
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,Chapter XIV Diseases of the genitourinary system,Erosion and ectropion of cervix uteri,9784,72,1.15 [0.93-1.42],0.1995581856688267
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,Chapter XIV Diseases of the genitourinary system,Dysplasia of cervi uteri,9841,129,1.12 [0.95-1.31],0.1678730561150525
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,Chapter XIV Diseases of the genitourinary system,"All dysplastic lesions of the cervix uteri, vagina or vulva",13300,178,1.12 [0.98-1.28],0.1080849137019659
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,Chapter XIV Diseases of the genitourinary system,All dysplastic lesions of the cervix uteri,13308,171,1.11 [0.97-1.27],0.1353359013177111
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,Chapter XIV Diseases of the genitourinary system,HSIL lesion of the cervix uteri,13324,97,1.13 [0.94-1.36],0.1832486413296009
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,Chapter XIV Diseases of the genitourinary system,"HSIL lesion of the cervix uteri, vagina or vulva",13317,105,1.13 [0.95-1.35],0.1608244472834812
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,Chapter XIV Diseases of the genitourinary system,Other noninflammatory disorders of cervix uteri,9774,62,0.90 [0.71-1.13],0.3489611036791723
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,Chapter XIV Diseases of the genitourinary system,Other noninflammatory disorders of vagina,9765,53,0.94 [0.73-1.20],0.6013921129446562
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,Chapter XIV Diseases of the genitourinary system,Other noninflammatory disorders of vulva and perineum,9774,62,0.83 [0.66-1.05],0.122281515400743
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,Chapter XIV Diseases of the genitourinary system,Irregular menses,13236,329,1.07 [0.96-1.18],0.2093374458421797
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,Chapter XIV Diseases of the genitourinary system,"Excessive, frequent and irregular menstruation",10702,990,1.01 [0.95-1.07],0.7076177635908099
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,Chapter XIV Diseases of the genitourinary system,Menorrhagia,10388,676,0.99 [0.92-1.06],0.7341324576202121
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",13310,143,0.94 [0.81-1.10],0.4466250619517229
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,Chapter XIV Diseases of the genitourinary system,Other abnormal uterine and vaginal bleeding,10018,306,0.97 [0.88-1.08],0.5774132659723865
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,Chapter XIV Diseases of the genitourinary system,Pain and other conditions associated with female genital organs and menstrual cycle,9939,227,0.95 [0.84-1.07],0.3836667374819276
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,Chapter XIV Diseases of the genitourinary system,Postmenopausal bleeding,9939,227,1.02 [0.91-1.15],0.7292334434319605
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,Chapter XIV Diseases of the genitourinary system,Female infertility,9796,84,1.15 [0.94-1.40],0.1655223728921713
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,Chapter XIV Diseases of the genitourinary system,"Female infertility, cervigal, vaginal, other or unspecified origin",9789,77,1.16 [0.94-1.42],0.1684931464995566
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,"Chapter XV Pregnancy, childbirth and the puerperium",Maternal care related to the fetus and amniotic cavity and possible delivery problems,13316,724,1.07 [1.00-1.15],0.0658184828023005
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,"Chapter XV Pregnancy, childbirth and the puerperium",Complications of labour and delivery,13323,1001,1.09 [1.02-1.17],0.0082846253321241
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,"Chapter XV Pregnancy, childbirth and the puerperium",Pregnancy with abortive outcome,13317,383,1.08 [0.98-1.19],0.1241592914157195
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,"Chapter XV Pregnancy, childbirth and the puerperium",Other abnormal products of conception,13040,106,1.15 [0.97-1.37],0.11416542588265
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,"Chapter XV Pregnancy, childbirth and the puerperium",Spontaneous abortion,13088,154,1.02 [0.88-1.18],0.8023972157392957
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,"Chapter XV Pregnancy, childbirth and the puerperium",Medical abortion,13072,138,1.13 [0.96-1.32],0.1369934061620664
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,"Chapter XV Pregnancy, childbirth and the puerperium","Oedema, proteinuria and hypertensive disorders in pregnancy, childbirth and the puerperium",13333,140,1.05 [0.90-1.22],0.5730924472558931
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,"Chapter XV Pregnancy, childbirth and the puerperium",Pregnancy hypertension,13335,138,1.05 [0.90-1.23],0.5323612466161544
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,"Chapter XV Pregnancy, childbirth and the puerperium",Other maternal disorders predominantly related to pregnancy,13333,358,1.01 [0.91-1.12],0.8422481411427194
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,"Chapter XV Pregnancy, childbirth and the puerperium",Haemorrhage in early pregnancy,13081,106,0.85 [0.71-1.02],0.0816785393925222
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,"Chapter XV Pregnancy, childbirth and the puerperium",Maternal care for other conditions predominantly related to pregnancy,13176,201,1.06 [0.93-1.21],0.380588646414966
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,"Chapter XV Pregnancy, childbirth and the puerperium",Maternal care for known or suspected malpresentation of fetus,12714,122,1.12 [0.95-1.33],0.1711032410096469
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,"Chapter XV Pregnancy, childbirth and the puerperium",Maternal care for known or suspected abnormality of pelvic organs,12760,168,1.11 [0.96-1.28],0.1643502539628345
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,"Chapter XV Pregnancy, childbirth and the puerperium",Maternal care for other known or suspected fetal problems,12794,202,1.05 [0.92-1.20],0.4434478485733598
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,"Chapter XV Pregnancy, childbirth and the puerperium",Premature rupture of membranes,12716,124,1.09 [0.92-1.28],0.3325457210133983
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,"Chapter XV Pregnancy, childbirth and the puerperium",False labour,12705,113,1.10 [0.93-1.31],0.2772160216575843
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,"Chapter XV Pregnancy, childbirth and the puerperium",Prolonged pregnancy,12717,125,0.95 [0.80-1.12],0.5456395029378549
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,"Chapter XV Pregnancy, childbirth and the puerperium",Long labour,12511,189,1.17 [1.02-1.33],0.0239070720502369
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,"Chapter XV Pregnancy, childbirth and the puerperium",Labour and delivery complicated by fetal stress [distress],12694,372,1.05 [0.95-1.16],0.318920107382621
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,"Chapter XV Pregnancy, childbirth and the puerperium",Perineal laceration during delivery,12871,549,1.13 [1.04-1.23],0.0033937709454738
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,"Chapter XV Pregnancy, childbirth and the puerperium","Postpartum hemorraghe, all women as controls",13338,148,1.08 [0.93-1.25],0.335668063084527
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,"Chapter XV Pregnancy, childbirth and the puerperium",Postpartum haemorrhage due to anatomy,12133,113,1.06 [0.89-1.26],0.4955408756599504
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,"Chapter XV Pregnancy, childbirth and the puerperium","Other complications of labour and delivery, not elsewhere classified",12406,84,0.99 [0.81-1.21],0.9073665113948676
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,"Chapter XV Pregnancy, childbirth and the puerperium",Delivery,13343,282,0.96 [0.86-1.08],0.5184222521354245
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,"Chapter XV Pregnancy, childbirth and the puerperium",Single spontaneous delivery,13279,218,0.98 [0.86-1.11],0.7186172695992337
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,"Chapter XV Pregnancy, childbirth and the puerperium","Other obstetric conditions, not elsewhere classified",13332,212,1.04 [0.92-1.18],0.5233235635383333
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,"Chapter XV Pregnancy, childbirth and the puerperium","Other maternal diseases classifiable elsewhere but complicating pregnancy, childbirth and the puerperium",13322,202,1.03 [0.90-1.17],0.694296449918164
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,Chapter IX Diseases of the circulatory system,"Bradycardia, unspecified, drug-induced",23943,32,0.82 [0.60-1.13],0.2267248893199803
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,Chapter VI Diseases of the nervous system,Falls/tendency to fall,22716,448,0.90 [0.82-0.98],0.0119770181081125
